The 20 Best Non-Muscle Invasive Bladder Cancer Doctors Near Me in Hanover, MD

Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology.

Rian Dickstein is a Urologist practicing medicine in Hanover, Maryland. Dr. Dickstein is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy.

Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Reconstruction, and Nephrectomy. Dr. Hoffman is board certified in American Board Of Internal Medicine.

Peter Filderman is a Urologist practicing medicine in Baltimore, Maryland. Dr. Filderman is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), UPJ Obstruction, Urinary Tract Infection in Children, Ureteroscopy, and Bladder Reconstruction. Dr. Filderman is board certified in American Board Of Urology.

Frank Nezu is a Urologist practicing medicine in Columbia, Maryland. Dr. Nezu is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, Boils, and Ureteroscopy. Dr. Nezu is board certified in American Board Of Urology.

Alejandro Rodriguez is a Urologist practicing medicine in Columbia, Maryland. Dr. Rodriguez is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), UPJ Obstruction, Kidney Stones, Familial Prostate Cancer, and Ureteroscopy. Dr. Rodriguez is board certified in American Board Of Urology.

Ilene S. Browner, M.D. specializes in geriatric oncology. Dr. Browner is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Endoscopy. Dr. Browner is board certified in American Board Of Internal Medicine.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine.

Jessica Engle, D.O., is a rehabilitation physician specializing in cancer rehabilitation, with clinic locations in the Baltimore metropolitan area and Washington. Dr. Engle uses a multidisciplinary approach to treat the whole patient throughout the cancer care continuum. Her focus is on addressing cancer and impairments related to cancer treatment. She aims to improve quality of life, and maintain and improve function whenever possible. Dr. Engle is an assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. She completed a fellowship in cancer rehabilitation at the University of Texas MD Anderson Cancer Center after a physical medicine and rehabilitation residency at Stony Brook University. Videos Dr. Jessica Engle. Dr. Engle is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Lymphedema, and Meige Disease. Dr. Engle is board certified in American Board Of Physical Medicine And Rehabilitation.

Sunil H. Patel, M.D., M.A., is an Assistant Professor of Urology and Oncology at the School of Medicine at Johns Hopkins. He serves as and the Director of the Urologic Oncology Fellowship. He also serves as Director of the Testicular Cancer program. He treats all urologic malignancies, including adrenal cancer, kidney cancer, urothelial cancer, bladder cancer, prostate cancer, testes cancer, and penile cancers. Additionally, he has advanced training in complex robotic and open surgical cases. His clinical and research focus is in Urologic Oncology, with areas of focus in bladder cancer, testes cancer, and kidney cancer. Dr. Patel completed his undergraduate studies at California Polytechnic State University, San Luis Obispo where he studied Biological Sciences. He completed his Masters at Boston University, completing his thesis on microfluidics, afterwards completing his medical degree at Boston University. He completed his general surgery internship and urology residency at University of California, San Diego. He continued his training through a Society of Urologic Oncology Fellowship in urologic oncology at the Johns Hopkins Hospital. He joined Johns Hopkins in June 2020 with interests in environmental factors contributing to oncogenesis in urological cancers, especially bladder cancer. He is dedicated to international health and works closely with international volunteers in urology and has done several mission trips and guest lectures. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Patel is board certified in American Board Of Urology.

Zhanna Kalikhman is a primary care provider, practicing in Internal Medicine in Elkridge, Maryland. Dr. Kalikhman is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Kalikhman is board certified in American Board Of Internal Medicine.

Geoffrey Sklar is a Urologist practicing medicine in Hanover, Maryland. Dr. Sklar is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Penile Cancer, Urothelial Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Ureteroscopy.

David Mcdermott is a Urologist practicing medicine in Glen Burnie, Maryland. Dr. Mcdermott is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Congenital Mesoblastic Nephroma, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Jiakai Zhu is a Urologist practicing medicine in Glen Burnie, Maryland. Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Urinary Tract Infection in Children, and Ureteroscopy.

Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider practicing medicine in Columbia, Maryland. Dr. Nimmagadda is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma. Dr. Nimmagadda is board certified in American Board Of Internal Medicine.

Kenneth Langer is a Urologist practicing medicine in Baltimore, Maryland. Dr. Langer is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Incontinence, Frequent or Urgent Urination, Urinary Tract Infection in Children, and Ureteroscopy. Dr. Langer is board certified in American Board Of Urology.

Vladimir Kakitelashvili is a Urologist practicing medicine in Glen Burnie, Maryland. Dr. Kakitelashvili is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Orchitis, Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant. Dr. Narang is board certified in American Board Of Internal Medicine.

Katherine Smentkowski is a Plastic Surgeon and a Urologist practicing medicine in Columbia, Maryland. Dr. Smentkowski is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Ureterocele, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Reconstructive Urology Surgery, and Ureteroscopy. Dr. Smentkowski is board certified in American Board Of Urology.